Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of the ILB-3101 in Patients with Advanced Solid Tumors

ILB-3101 is a fully humanized IgG1 antibody-drug conjugate (ADC) which specifically binds to B7-H3, a target wildly expressed on solid tumor cells. The objectives of this study are to investigate the safety, tolerability, pharmacokinetics and anti-tumor activity of ILB-3101 in Chinese advanced solid tumor patients.

Participants needed: 240
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Innolake BiopharmUpdated: Dec 9, 2024Locations: 1
Eligibility criteria

Have signed informed consent forms voluntarily. [+18]

Received urea nitrite or mitomycin C within 6 weeks prior to the first use of th... [+27]

Read more
Status: Recruiting

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

This is a multicenter, open-label, phase Ib/IIa study. The first part of the study will evaluate the safety, tolerability and preliminary efficacy of ILB2109 and Toripalimab in patients with locally advanced or metastatic solid malignancies. The second part of the study will evaluate the efficacy of ILB2109 and Toripalimab in patients with selected advanced solid malignancies.

Participants needed: 200
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Innolake BiopharmUpdated: May 21, 2024Locations: 1
Eligibility criteria

Adult patients between the ages of 18 and 80 years. [+7]

In the past 3 weeks: received systemic anti-tumor therapy, including chemotherap... [+23]

Read more